MW 188.3 Da, Purity >98%. Irreversible, competitive Thioredoxin-1 inhibitor (Ki = 30.8 μM). Attenuates HIF-1α, VEGF and iNOS expression (IC50 values are 7.2, 10.4 and 18.1 μM, respectively). Inhibits tubulin and decreases tumor blood vessel density. Shows antitumor effects in vivo..
MW 188.3 Da, Purity >98%. Irreversible, competitive Thioredoxin-1 inhibitor (Ki = 30.8 μM). Attenuates HIF-1α, VEGF and iNOS expression (IC50 values are 7.2, 10.4 and 18.1 μM, respectively). Inhibits tubulin and decreases tumor blood vessel density. Shows antitumor effects in vivo..
Soluble in DMSO to 100 mM.
Irreversible, competitive Thioredoxin-1 inhibitor (Ki = 30.8 μM). Attenuates HIF-1α, VEGF and iNOS expression (IC50 values are 7.2, 10.4 and 18.1 μM, respectively). Inhibits tubulin and decreases tumor blood vessel density. Shows antitumor effects in vivo.
This product is manufactured by BioVision, an Abcam company and was previously called 2217 PX 12. 2217-25 is the same size as the 25 mg size of ab146140.
We are dedicated to supporting your work with high quality reagents and we are here for you every step of the way should you need us.
In the unlikely event of one of our products not working as expected, you are covered by our product promise.
Full details and terms and conditions can be found here:
Terms & Conditions.
2D chemical structure image of ab146140, PX 12, Thioredoxin-1 inhibitor
Please note: All products are 'FOR RESEARCH USE ONLY. NOT FOR USE IN DIAGNOSTIC OR THERAPEUTIC PROCEDURES'.
For licensing inquiries, please contact partnerships@abcam.com